{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:40:37Z","timestamp":1792795237604,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.beem.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:21:24Z","timestamp":1538144484000},"page":"781-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Genetics of parathyroids disorders: Overview"],"prefix":"10.1016","volume":"32","author":[{"given":"Falchetti","family":"Alberto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2018.09.011_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.09.011_bib2","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.beem.2018.09.011_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/eje.0.1430047","article-title":"Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism","volume":"143","author":"Miedlich","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"10.1016\/j.beem.2018.09.011_bib5","first-page":"5553","article-title":"Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors","volume":"60","author":"Uchino","year":"2000","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.beem.2018.09.011_bib6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF03345303","article-title":"Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics","volume":"27","author":"Scarpelli","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.beem.2018.09.011_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF03346498","article-title":"Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition","volume":"32","author":"Vierimaa","year":"2009","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"8","key":"10.1016\/j.beem.2018.09.011_bib8","first-page":"2617","article-title":"Multiple endocrine neoplasia\u2013syndromes of the twentieth century","volume":"83","author":"Thakker","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.011_bib9","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7230.1","article-title":"Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old","volume":"6","author":"Falchetti","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.2009.02105.x","article-title":"DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes","volume":"266","author":"Falchetti","year":"2009","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10689-010-9398-6","article-title":"Care for patients with multiple endocrine neoplasia type 1: the current evidence base","volume":"10","author":"Pieterman","year":"2011","journal-title":"Fam Cancer"},{"key":"10.1016\/j.beem.2018.09.011_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)80967-8","article-title":"Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription","volume":"96","author":"Agarwal","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.beem.2018.09.011_bib13","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1038\/sj.onc.1204529","article-title":"The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation","volume":"20","author":"Heppner","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2018.09.011_bib14","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1073\/pnas.061358098","article-title":"Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling","volume":"98","author":"Kaji","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2018.09.011_bib15","series-title":"The parathyroids basic and clinical concepts","first-page":"279","author":"Arnold","year":"2015"},{"issue":"2","key":"10.1016\/j.beem.2018.09.011_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cen.12714","article-title":"Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1-case report and review of the literature","volume":"84","author":"Singh Ospina","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.09.011_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","article-title":"Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature","volume":"31","author":"Christakis","year":"2016","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/ol.2017.6162","article-title":"Novel association of MEN1 gene mutations with parathyroid carcinoma","volume":"14","author":"Cinque","year":"2017","journal-title":"Oncol Lett"},{"issue":"Suppl 3","key":"10.1016\/j.beem.2018.09.011_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4158\/EP11062.RA","article-title":"Are microRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1?","volume":"17","author":"Luzi","year":"2011","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.beem.2018.09.011_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/cgt.2010.39","article-title":"Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients","volume":"17","author":"Luzi","year":"2010","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"10.1016\/j.beem.2018.09.011_bib21","first-page":"1743","article-title":"Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas","volume":"9","author":"Luzi","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.beem.2018.09.011_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/humu.20928","article-title":"Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype\/phenotype correlations","volume":"30","author":"Margraf","year":"2009","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.beem.2018.09.011_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 2A","volume":"238","author":"Raue","year":"1995","journal-title":"J\u00a0Intern Med"},{"issue":"7","key":"10.1016\/j.beem.2018.09.011_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s002689900123","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs \u00e1 Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons","volume":"20","author":"Kraimps","year":"1996","journal-title":"World J Surg"},{"issue":"8","key":"10.1016\/j.beem.2018.09.011_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/1043-2760(95)00151-4","article-title":"The practical management of multiple endocrine neoplasia","volume":"6","author":"Learoyd","year":"1995","journal-title":"Trends Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0889-8529(18)30126-9","article-title":"Current perspectives on the diagnosis and management of patients with multiple endocrine neoplasia type 2 syndromes","volume":"23","author":"Wells","year":"1994","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"10.1016\/j.beem.2018.09.011_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2010.02.001","article-title":"Multiple endocrine neoplasia type 2","volume":"24","author":"Wohllk","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.09.011_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000345675","article-title":"Genetic defects associated with familial and sporadic hyperparathyroidism","volume":"41","author":"Hendy","year":"2013","journal-title":"Front Horm Res. Basel, Karger"},{"issue":"19","key":"10.1016\/j.beem.2018.09.011_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.beem.2018.09.011_bib30","first-page":"1600","article-title":"Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland","volume":"147","author":"Padberg","year":"1995","journal-title":"Am J Pathol"},{"issue":"42","key":"10.1016\/j.beem.2018.09.011_bib31","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.beem.2018.09.011_bib32","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.09.011_bib33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2018.09.011_bib34","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A\u00a0novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.beem.2018.09.011_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-11-0929","article-title":"Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2018.09.011_bib36","doi-asserted-by":"crossref","first-page":"e1003350","DOI":"10.1371\/journal.pgen.1003350","article-title":"A\u00a0novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.beem.2018.09.011_bib37","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-14-0080","article-title":"A\u00a0heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.09.011_bib38","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2018.09.011_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mpdhp.2016.02.003","article-title":"Familial hyperparathyroidism syndromes","volume":"22","author":"Duan","year":"2016","journal-title":"Diagn Histopathol"},{"issue":"4","key":"10.1016\/j.beem.2018.09.011_bib40","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.beem.2018.09.011_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2013.09.005","article-title":"Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors","volume":"386","author":"Costa-Guda","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2018.09.011_bib42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","article-title":"Parafibromin-functional insights","volume":"266","author":"Newey","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.09.011_bib43","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1038\/ncomms6433","article-title":"Cytoplasmic parafibromin\/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis","volume":"5","author":"Jo","year":"2014","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.beem.2018.09.011_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"issue":"18","key":"10.1016\/j.beem.2018.09.011_bib45","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2018.09.011_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2265.2010.03870.x","article-title":"A\u00a0homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia","volume":"73","author":"Hannan","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"10.1016\/j.beem.2018.09.011_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2265.2011.04059.x","article-title":"Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism","volume":"75","author":"Frank-Raue","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"10.1016\/j.beem.2018.09.011_bib49","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.09.011_bib50","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","article-title":"Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome","volume":"89","author":"Simonds","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.09.011_bib52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2018.09.011_bib53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2018.09.011_bib54","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/js.2017-00043","article-title":"Ethnicity of patients with germline GCM2 activating variants and primary hyperparathyroidism","volume":"1","author":"Guan","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"issue":"3","key":"10.1016\/j.beem.2018.09.011_bib55","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/jmg.2005.035766","article-title":"Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14","volume":"43","author":"Warner","year":"2006","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.beem.2018.09.011_bib56","first-page":"3107","article-title":"Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors","volume":"80","author":"Hosokawa","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2018.09.011_bib57","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1359\/jbmr.1999.14.6.878","article-title":"No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas","volume":"14","author":"Cetani","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.beem.2018.09.011_bib58","first-page":"3481","article-title":"Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism","volume":"82","author":"Farnebo","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"26","key":"10.1016\/j.beem.2018.09.011_bib59","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2018.09.011_bib60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ecl.2017.01.006","article-title":"Genetics of hyperparathyroidism, including parathyroid cancer","volume":"46","author":"Simonds","year":"2017","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"5","key":"10.1016\/j.beem.2018.09.011_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12672-013-0147-9","article-title":"Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas","volume":"4","author":"Costa-Guda","year":"2013","journal-title":"Horm Cancer"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18301118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:52:43Z","timestamp":1761497563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18301118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1521690X18301118"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.011","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of parathyroids disorders: Overview","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}